Life Sciences Conferences

The Japan Biotech Meeting

Agenda

---

Day 1: Monday September 29, 2008

General Program
9:00: Registration Opens, Foyer
9:15–9:30: Opening Remarks
G. Steven Burrill, CEO, Burrill & Comany
9:30–11: Keynote: Biotech 2008—A 20/20 Vision to 2020
G. Steven Burrill, CEO, Burrill & Comany
11:00–12:00: Keynote Dialogue
Takaaki Kameda MD. PhD, Chairman of the Board, CEO, Kameda Medical Center
Moderated by  G. Steven Burrill, CEO, Burrill & Comany
12:00–13:00: Networking Luncheon, Foyer
13:00–15:00: Industry leaders share their vision of the future
Gregory Bogfiglio JD, Managing Partner, Proteus Venture Partners
Ichiro Nakatomi, PhD, Chairman and CEO, NanoCarrier, Inc
Moderated by  G. Steven Burrill, CEO, Burrill & Comany
15:00–15:15: Coffee Break, Foyer
15:15–16:45: Capital markets in really tough times—will there be capital available to fuel the industry?
Zhi yang, PhD, Chairman, and CEO, Bioveda China Fund
An Hanham, PhD, Managing Director, Burrill & Company
Moderated by Tsunehiko Yanagihara, General Manager, Mitsubishi Corporation
16:45–17:00: Closing Remarks
Jun Ikeda, SVP, Advanced Sciences & Technology Division COO, Mitsubishi Corporation
17:00–19:00: Networking Reception

Day 2: Tuesday September 30, 2008

General Program
9:00: Registration Opens, Foyer
9:15–9:30: Opening Remarks
Tsunehiko Yanagihara, General Manager, Mitsubishi Corporation
9:30–10:30: A response—a vision for Japan—Biotechnology Industry
Hiroaki Hashimoto, Editor in Chief, Nikkei Biotechnology and Business
11:30–12:00: Industry leaders share their vision of the future—Chinese biotechs and IP
Samantha Du, PhD, CEO, Hutchinson Medipharma
James Zhu, PhD, JD, Perkins Coie
Moderated by An Hanham, PhD, Managing Director, Burrill & Company
12:00–13:00: Networking Lunch, Foyer
13:00–15:00: Industry leaders share their vision of the future—Generics in Japan and China
15:00–15:15: Coffee Break, Foyer
15:15–16:45: A response—A vision for China
Zhi yang, PhD, Chairman, and CEO, Bioveda China Fund
James Zhu, PhD, JD, Perkins Coie
Stephen M. Sammut, Venture Partner, Burrill & Company
16:45–17:00: Closing Remarks, Grand
An Hanham, PhD, Managing Director, Burrill & Company